summary
Introduced
02/25/2025
02/25/2025
In Committee
02/25/2025
02/25/2025
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
Amending the act of September 27, 1961 (P.L.1700, No.699), entitled "An act relating to the regulation of the practice of pharmacy, including the sales, use and distribution of drugs and devices at retail; and amending, revising, consolidating and repealing certain laws relating thereto," providing for price disclosure.
AI Summary
This bill amends the Pharmacy Act to require pharmacies to provide specific price and insurance-related disclosures to consumers upon request when purchasing prescription medications. Pharmacies must disclose the current retail price of brand-name and generic drugs, the consumer's cost-sharing amount, and information about applying for subsidized health coverage through the state's health insurance exchange. Pharmacies must also post a notice informing consumers of their right to request these disclosures and keep an updated copy of the law on file. The bill includes a consumer-friendly disclaimer advising that healthcare choices should not be based solely on the provided information. Pharmacies that fail to comply can be fined up to $500. The law defines several key terms, including "cost-sharing amount," "exchange authority," and "pharmacy benefits manager." The bill also establishes that certain sections will take effect immediately, while the remainder of the act will take effect one year after passage, with the goal of increasing transparency in prescription drug pricing and helping consumers make more informed healthcare decisions.
Committee Categories
Business and Industry
Sponsors (8)
Vincent Hughes (D)*,
Carolyn Comitta (D),
Jay Costa (D),
Art Haywood (D),
Nick Miller (D),
Judy Schwank (D),
Sharif Street (D),
Lindsey Williams (D),
Last Action
Referred to Banking & Insurance (on 02/25/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...